Home/Filings/4/0001209191-20-058171
4//SEC Filing

Chiang Kyle 4

Accession 0001209191-20-058171

CIK 0001664106other

Filed

Nov 11, 7:00 PM ET

Accepted

Nov 12, 8:00 PM ET

Size

5.3 KB

Accession

0001209191-20-058171

Insider Transaction Report

Form 4
Period: 2020-11-02
Chiang Kyle
Chief Operating Officer
Transactions
  • Award

    Stock Option (right to buy)

    2020-11-02+85,00085,000 total
    Exercise: $5.65Exp: 2030-11-02Common Stock (85,000 underlying)
Footnotes (1)
  • [F1]25% vests on 11/02/2021 and the remainder vests in equal monthly installments over the next 36 months.

Issuer

LogicBio Therapeutics, Inc.

CIK 0001664106

Entity typeother

Related Parties

1
  • filerCIK 0001831341

Filing Metadata

Form type
4
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 8:00 PM ET
Size
5.3 KB